{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T18:57:02Z","timestamp":1781463422719,"version":"3.54.1"},"reference-count":9,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ijid.2026.108704","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T20:33:10Z","timestamp":1776285190000},"page":"108704","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Virological outcomes of PWH who discontinued cabotegravir\/rilpivirine long-acting therapy in a real-world context"],"prefix":"10.1016","volume":"168","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6351-2623","authenticated-orcid":false,"given":"Roberta","family":"Gagliardini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5899-451X","authenticated-orcid":false,"given":"Alessandro","family":"Tavelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Mazzotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo Roberto","family":"Raccagni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas Brian","family":"Bana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Squillace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla","family":"Muccini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Giacomelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Saracino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Marchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella d\u2019Arminio","family":"Monforte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Antinori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2026.108704_bib0001","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1093\/jac\/dkae480","article-title":"Safety and efficacy of long-acting cabotegravir\/rilpivirine versus standard oral antiretroviral therapy: a systematic review and meta-analysis","volume":"80","author":"Manalu","year":"2025","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijid.2026.108704_bib0002","unstructured":"EACS guidelines version 13.0, October 2025."},{"key":"10.1016\/j.ijid.2026.108704_bib0004","series-title":"Abstract","article-title":"Long-term CAB+RPV LA effectiveness in virologically suppressed individuals in the OPERA cohort","volume":"674","author":"Sension","year":"2025"},{"key":"10.1016\/j.ijid.2026.108704_bib0005","article-title":"Outcomes on cabotegravir + rilpivirine in suppressed people with HIV (PWH) in TRIO health US cohort. San Franisco, US; CROI; 2025","volume":"675","author":"Sax","year":"2025","journal-title":"Abstract"},{"key":"10.1016\/j.ijid.2026.108704_bib0006","doi-asserted-by":"crossref","DOI":"10.1093\/jac\/dkaf184","article-title":"Effectiveness and predictors of treatment discontinuation of long-acting cabotegravir\/rilpivirine in virologically suppressed people with HIV: real-life data from the Icona cohort","author":"Gagliardini","year":"2025","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijid.2026.108704_bib0007","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofae326","article-title":"One year of long-acting cabotegravir and rilpivirine in people with Human immunodeficiency virus and long exposure to antiretroviral therapy: data from the SCohoLART study","volume":"11","author":"Muccini","year":"2024","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.ijid.2026.108704_bib0008","doi-asserted-by":"crossref","DOI":"10.1111\/hiv.70057","article-title":"Long-acting injectable cabotegravir and rilpivirine in observational cohort studies: a systematic review on virological failure, resistance and re-suppression outcomes in virally suppressed individuals living with HIV","author":"Ring","year":"2025","journal-title":"HIV Med"},{"key":"10.1016\/j.ijid.2026.108704_bib0009","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofaf600","article-title":"Discontinuation of long-acting injectable Cabotegravir\u2013Rilpivirine in a large clinic cohort","volume":"12","author":"Christopoulos","year":"2025","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.ijid.2026.108704_bib0010","article-title":"Predictors of discontinuing injectable cabotegravir\/rilpivirine and virologic outcomes after resuming oral antiretroviral therapy","author":"Faggiano","year":"2025","journal-title":"HIV Med"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971226003395?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971226003395?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T18:18:50Z","timestamp":1781461130000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971226003395"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":9,"alternative-id":["S1201971226003395"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2026.108704","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Virological outcomes of PWH who discontinued cabotegravir\/rilpivirine long-acting therapy in a real-world context","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2026.108704","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}],"article-number":"108704"}}